Percent of Male Medicare Beneficiaries Age 75 and Older Having a Screening PSA Test
  • Print
  • PDF
  • Embed

    Copy the following code and paste it into your website in order to display the current report.

  • Download to Excel

Customize Report

    • YEAR:

    Choose Locations

    [clear all] [select all] Selected Locations:

      Choose Indicator(s)

      Select one or more indicators
      • TOPIC:
      • INDICATOR:
      • YEAR:

      [clear all] Selected Indicators:


    (Click a region name
    below to view its profile)
    Percent of Male Medicare Beneficiaries Age 75 and Older Having a Screening PSA Test
    (Year: 2014; Region Levels: State)
    Wyoming 11.1%
    Wisconsin 12.1%
    West Virginia 17.2%
    Washington 12.6%
    Virginia 15.3%
    Vermont 9.7%
    Utah 14.1%
    Texas 19.0%
    Tennessee 20.8%
    South Dakota 15.8%
    South Carolina 19.9%
    Rhode Island 16.7%
    Pennsylvania 17.0%
    Oregon 12.6%
    Oklahoma 18.6%
    Ohio 17.3%
    North Dakota 16.1%
    North Carolina 17.7%
    New York 21.6%
    New Mexico 13.3%
    New Jersey 21.2%
    New Hampshire 12.0%
    Nevada 15.3%
    Nebraska 16.1%
    Montana 14.0%
    Missouri 16.8%
    Mississippi 19.8%
    Minnesota 10.5%
    Michigan 20.8%
    Massachusetts 15.1%
    Maryland 15.9%
    Maine 9.6%
    Louisiana 20.5%
    Kentucky 18.0%
    Kansas 18.3%
    Iowa 14.3%
    Indiana 17.1%
    Illinois 18.0%
    Idaho 14.2%
    Hawaii 19.9%
    Georgia 21.9%
    Florida 23.0%
    District of Columbia 15.0%
    Delaware 17.2%
    Connecticut 16.7%
    Colorado 12.8%
    California 18.9%
    Arkansas 18.2%
    Arizona 18.9%
    Alaska 12.6%
    Alabama 23.2%
    National Average 18.2%
    90th Percentile 20.8%
    50th Percentile 16.8%
    10th Percentile 12.1%
        • FOOTNOTES:
        • PSA screening rates are not adjusted; because the measure is already restricted by age and sex, statistical adjustments to correct for underlying population differences are not relevant.

        • The denominator consisted of male Medicare enrollees age 75-99 on January 1, 2012 who were eligible for Medicare Parts A and B and not enrolled in risk-bearing HMOs at any time during the year. Excluded from the analysis were men who had a PSA test for a presumed screening indication, men who had any history of prostate disease (prostate cancer, prostate surgery, or diagnosis of elevated PSA in the prior three years), and men who had prostate cancer-like symptoms in the three months before a PSA test based on diagnostic codes billed on visits and hospitalizations.

        • PSA screening was defined as any, but only one occurrence per patient during 2012 of CPT codes G0103 and 84153.


    © 2018 The Trustees of Dartmouth College | 35 Centerra Parkway, Lebanon, NH 03766 | (603) 653-0800

    The Dartmouth Atlas of Health Care is based at The Dartmouth Institute for Health Policy and Clinical Practice and is supported by a coalition of funders led by the Robert Wood Johnson Foundation, including the WellPoint Foundation, the United Health Foundation, the California HealthCare Foundation, and the Charles H. Hood Foundation.